WAVE Life Sciences Ltd.
WVE
$6.73
-$0.06-0.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 279.95% | -951.90% | -56.00% | -15.15% | 62.81% |
| Total Depreciation and Amortization | -1.19% | -4.68% | -6.46% | -10.71% | -12.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.93% | 54.60% | 44.67% | 4.76% | -19.42% |
| Change in Net Operating Assets | -263.90% | 120.78% | 99.03% | -106.43% | -543.19% |
| Cash from Operations | -31.32% | -34.89% | 26.27% | -139.09% | 0.60% |
| Capital Expenditure | 75.84% | -93.43% | 27.78% | 14.72% | -74.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.84% | -93.43% | 27.78% | 14.72% | -101.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.75% | 11,256.05% | -64.68% | -58.61% | 159,157.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.77% | 12,100.36% | -64.68% | -58.61% | 170,740.00% |
| Foreign Exchange rate Adjustments | -277.59% | 475.00% | 19.00% | -252.38% | -38.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.66% | 575.53% | 24.26% | -116.17% | 815.00% |